Cargando…

Extracorporeal shockwave against inflammation mediated by GPR120 receptor in cyclophosphamide-induced rat cystitis model

BACKGROUND: We tested the hypothesis that extracorporeal shockwave treatment (ESWT) can abolish inflammation and restore urothelial barrier integrity in acute interstitial cystitis by upregulating the fatty acid receptor GPR120. METHODS: A total of 30 female Sprague-Dawley rats were categorized into...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Yi-Ling, Lin, Yuan-Ping, Sun, Cheuk-Kwan, Huang, Tien-Hung, Yip, Hon-Kan, Chen, Yen-Ta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6260739/
https://www.ncbi.nlm.nih.gov/pubmed/30482157
http://dx.doi.org/10.1186/s10020-018-0062-1
_version_ 1783374861008109568
author Chen, Yi-Ling
Lin, Yuan-Ping
Sun, Cheuk-Kwan
Huang, Tien-Hung
Yip, Hon-Kan
Chen, Yen-Ta
author_facet Chen, Yi-Ling
Lin, Yuan-Ping
Sun, Cheuk-Kwan
Huang, Tien-Hung
Yip, Hon-Kan
Chen, Yen-Ta
author_sort Chen, Yi-Ling
collection PubMed
description BACKGROUND: We tested the hypothesis that extracorporeal shockwave treatment (ESWT) can abolish inflammation and restore urothelial barrier integrity in acute interstitial cystitis by upregulating the fatty acid receptor GPR120. METHODS: A total of 30 female Sprague-Dawley rats were categorized into five groups: (1) sham-operated rats (SC); (2) rats treated with ESWT (SC + ESWT); (3) rats with bladder irritation using 150 mg/kg cyclophosphamide through intraperitoneal injection; (4) cyclophosphamide rats treated with ESWT (cyclophosphamide+ESWT); (5) cyclophosphamide rats treated with GPR120 agonist (cyclophosphamide+GW9508). RESULTS: On Day 3, urine and bladder specimens were collected for biochemical, histopathological, immunological, and immunoblotting analysis. Following stimulation with cyclophosphamide, the inhibition of the elevated levels of TAK1/NF-κB and phospho-TAK1/NF-κB by ESWT and GPR120 agonists in RT4 cells was associated with a suppression of NF-κB translocation from the cytosol to the nucleus. Accordingly, this anti-inflammatory effect was abolished by GPR120 antagonist and knockdown of GPR120. Histologically, bladder inflammation in cyclophosphamide-treated rats was suppressed by GW9508 or ESWT. Masson’s trichrome and Sirius red staining revealed that cyclophosphamide treatment enhanced synthesis of extracellular matrix in rats that was reversed by GW9508 or ESWT. Upregulated pro-inflammatory mediators and cytokines in the cyclophosphamide-treated rats were also suppressed in the GW9508- or ESWT-treated rats. The significantly increased inflammatory cell infiltration as well as the impaired urothelial integrity of the bladder after cyclophosphamide treatment were reversed by treatment with GW9508 or ESWT. CONCLUSIONS: These findings suggest that GPR120, the sensing receptor for ESWT, may be useful in the treatment of interstitial cystitis by inhibiting inflammatory response in bladder cells.
format Online
Article
Text
id pubmed-6260739
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-62607392018-12-03 Extracorporeal shockwave against inflammation mediated by GPR120 receptor in cyclophosphamide-induced rat cystitis model Chen, Yi-Ling Lin, Yuan-Ping Sun, Cheuk-Kwan Huang, Tien-Hung Yip, Hon-Kan Chen, Yen-Ta Mol Med Research Article BACKGROUND: We tested the hypothesis that extracorporeal shockwave treatment (ESWT) can abolish inflammation and restore urothelial barrier integrity in acute interstitial cystitis by upregulating the fatty acid receptor GPR120. METHODS: A total of 30 female Sprague-Dawley rats were categorized into five groups: (1) sham-operated rats (SC); (2) rats treated with ESWT (SC + ESWT); (3) rats with bladder irritation using 150 mg/kg cyclophosphamide through intraperitoneal injection; (4) cyclophosphamide rats treated with ESWT (cyclophosphamide+ESWT); (5) cyclophosphamide rats treated with GPR120 agonist (cyclophosphamide+GW9508). RESULTS: On Day 3, urine and bladder specimens were collected for biochemical, histopathological, immunological, and immunoblotting analysis. Following stimulation with cyclophosphamide, the inhibition of the elevated levels of TAK1/NF-κB and phospho-TAK1/NF-κB by ESWT and GPR120 agonists in RT4 cells was associated with a suppression of NF-κB translocation from the cytosol to the nucleus. Accordingly, this anti-inflammatory effect was abolished by GPR120 antagonist and knockdown of GPR120. Histologically, bladder inflammation in cyclophosphamide-treated rats was suppressed by GW9508 or ESWT. Masson’s trichrome and Sirius red staining revealed that cyclophosphamide treatment enhanced synthesis of extracellular matrix in rats that was reversed by GW9508 or ESWT. Upregulated pro-inflammatory mediators and cytokines in the cyclophosphamide-treated rats were also suppressed in the GW9508- or ESWT-treated rats. The significantly increased inflammatory cell infiltration as well as the impaired urothelial integrity of the bladder after cyclophosphamide treatment were reversed by treatment with GW9508 or ESWT. CONCLUSIONS: These findings suggest that GPR120, the sensing receptor for ESWT, may be useful in the treatment of interstitial cystitis by inhibiting inflammatory response in bladder cells. BioMed Central 2018-11-27 /pmc/articles/PMC6260739/ /pubmed/30482157 http://dx.doi.org/10.1186/s10020-018-0062-1 Text en © The Author(s) 2018 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research Article
Chen, Yi-Ling
Lin, Yuan-Ping
Sun, Cheuk-Kwan
Huang, Tien-Hung
Yip, Hon-Kan
Chen, Yen-Ta
Extracorporeal shockwave against inflammation mediated by GPR120 receptor in cyclophosphamide-induced rat cystitis model
title Extracorporeal shockwave against inflammation mediated by GPR120 receptor in cyclophosphamide-induced rat cystitis model
title_full Extracorporeal shockwave against inflammation mediated by GPR120 receptor in cyclophosphamide-induced rat cystitis model
title_fullStr Extracorporeal shockwave against inflammation mediated by GPR120 receptor in cyclophosphamide-induced rat cystitis model
title_full_unstemmed Extracorporeal shockwave against inflammation mediated by GPR120 receptor in cyclophosphamide-induced rat cystitis model
title_short Extracorporeal shockwave against inflammation mediated by GPR120 receptor in cyclophosphamide-induced rat cystitis model
title_sort extracorporeal shockwave against inflammation mediated by gpr120 receptor in cyclophosphamide-induced rat cystitis model
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6260739/
https://www.ncbi.nlm.nih.gov/pubmed/30482157
http://dx.doi.org/10.1186/s10020-018-0062-1
work_keys_str_mv AT chenyiling extracorporealshockwaveagainstinflammationmediatedbygpr120receptorincyclophosphamideinducedratcystitismodel
AT linyuanping extracorporealshockwaveagainstinflammationmediatedbygpr120receptorincyclophosphamideinducedratcystitismodel
AT suncheukkwan extracorporealshockwaveagainstinflammationmediatedbygpr120receptorincyclophosphamideinducedratcystitismodel
AT huangtienhung extracorporealshockwaveagainstinflammationmediatedbygpr120receptorincyclophosphamideinducedratcystitismodel
AT yiphonkan extracorporealshockwaveagainstinflammationmediatedbygpr120receptorincyclophosphamideinducedratcystitismodel
AT chenyenta extracorporealshockwaveagainstinflammationmediatedbygpr120receptorincyclophosphamideinducedratcystitismodel